Summary
38 / 100 · Bulios Score
What speaks for it
None of the indicators we track stands out on the positive side.
What to watch
- Revenue fell by 76% a year over the last 3 years.
- It passes only 1 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
Revenue fell by 76% a year over the last 3 years.
Growth in detailDoes it make money?
Where 100 USD of revenue goes
- Cost of sales 64 USD
- Research and development 12 USD
- Sales and administration 280 USD
- Taxes and other -555 USD
- Net profit 308 USD
Net profit, industry median (Renewable Utilities) 10 USD
Out of every 100 USD of revenue, 308 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
This revenue breakdown is on the way.
By region
This revenue breakdown is on the way.